{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:18:00Z","timestamp":1761607080725,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"am","delay-in-days":719,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008695","name":"Japan Foundation for Applied Enzymology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008695","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jchromb.2024.123993","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T15:49:06Z","timestamp":1705592946000},"page":"123993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Measurement of the intracellular active metabolites of thiopurine drugs to evaluate the enzymatic activity of nudix hydrolase 15 in human blood samples"],"prefix":"10.1016","volume":"1234","author":[{"given":"Hitomi","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Shibagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kuronuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Miyatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Mishiro-Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seisuke","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2118-442X","authenticated-orcid":false,"given":"Mitsuru","family":"Okuwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jchromb.2024.123993_b0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ped.13457","article-title":"Treatment and biology of pediatric acute lymphoblastic leukemia","volume":"60","author":"Kato","year":"2018","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.jchromb.2024.123993_b0010","article-title":"Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease","volume":"10","author":"Chande","year":"2015","journal-title":"Cochrane Database of Systematic Reviews."},{"issue":"5","key":"10.1016\/j.jchromb.2024.123993_b0015","article-title":"Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis","volume":"2016","author":"Timmer","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.jchromb.2024.123993_b0020","first-page":"173","article-title":"Demonstration of enzymatic activity converting azathioprine to 6-mercaptopurine","volume":"32","author":"Watanabe","year":"1978","journal-title":"Acta Med Okayama."},{"issue":"4","key":"10.1016\/j.jchromb.2024.123993_b0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","article-title":"The clinical pharmacology of 6-mercaptopurine","volume":"43","author":"Lennard","year":"1992","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2024.123993_b0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-6147(96)01007-3","article-title":"Thiopurine biology and pharmacology","author":"Aarbakke","year":"1997","journal-title":"Trends Pharmacol Sci England."},{"issue":"2","key":"10.1016\/j.jchromb.2024.123993_b0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/FTD.0b013e31820b42bb","article-title":"The role of inosine-5'-monophosphate dehydrogenase in thiopurine metabolism in patients with inflammatory bowel disease","volume":"33","author":"Haglund","year":"2011","journal-title":"Ther Drug Monit."},{"issue":"20","key":"10.1016\/j.jchromb.2024.123993_b0040","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/0006-2952(86)90623-4","article-title":"Concurrent unilateral chromatid damage and DNA strand breakage in response to 6-thioguanine treatment","volume":"35","author":"Fairchild","year":"1986","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.jchromb.2024.123993_b0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/jpet.104.074815","article-title":"Selective inhibition of inflammatory gene expression in activated T Lymphocytes: a mechanism of immune suppression by thiopurines","volume":"312","author":"Thomas","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.jchromb.2024.123993_b0050","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00535-021-01820-0","article-title":"Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutation","volume":"56","author":"Toyonaga","year":"2021","journal-title":"J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jchromb.2024.123993_b0055","first-page":"950","article-title":"The incorporation of 6-thioguanine into RNA fractions and its effect on RNA and protein biosynthesis in mouse sarcoma 180 ascites cells","volume":"33","author":"Kwan","year":"1973","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.jchromb.2024.123993_b0060","first-page":"3721","article-title":"Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint","volume":"55","author":"Hawn","year":"1995","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.jchromb.2024.123993_b0065","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.jchromb.2024.123993_b0070","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4049\/jimmunol.176.1.640","article-title":"Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of vav guanosine exchange activity on rac proteins","volume":"176","author":"Poppe","year":"2006","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.jchromb.2024.123993_b0075","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1021\/bi801467z","article-title":"6-Thioguanine perturbs cytosine methylation at the CpG dinucleotide site by DNA methyltransferases in vitro and acts as a DNA demethylating agent in Vivo","volume":"48","author":"Wang","year":"2009","journal-title":"Biochemistry."},{"issue":"8","key":"10.1016\/j.jchromb.2024.123993_b0080","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/gut.34.8.1081","article-title":"Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience","volume":"34","author":"Connell","year":"1993","journal-title":"Gut."},{"issue":"8","key":"10.1016\/j.jchromb.2024.123993_b0085","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pds.926","article-title":"Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease","volume":"13","author":"Gearry","year":"2004","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"7","key":"10.1016\/j.jchromb.2024.123993_b0090","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1572-0241.2008.01848.x","article-title":"Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review","volume":"103","author":"Gisbert","year":"2008","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"10.1016\/j.jchromb.2024.123993_b0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4292\/wjgpt.v5.i2.63","article-title":"Use of thiopurines in inflammatory bowel disease: Safety issues","volume":"5","author":"Konidari","year":"2014","journal-title":"World J. Gastrointestinal Pharmacology and Therapeutics."},{"issue":"6","key":"10.1016\/j.jchromb.2024.123993_b0100","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MEG.0000000000001078","article-title":"Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort","volume":"30","author":"Godat","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jchromb.2024.123993_b0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/bjh.13518","article-title":"Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia","volume":"171","author":"Tanaka","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.jchromb.2024.123993_b0110","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.3324\/haematol.2020.266320","article-title":"An international retrospective study for tolerability of 6-mercaptopurine on NUDT15 bi-allelic variants in children with acute lymphoblastic leukemia","volume":"106","author":"Tanaka","year":"2021","journal-title":"Haematologica."},{"issue":"9","key":"10.1016\/j.jchromb.2024.123993_b0115","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ng.3060","article-title":"A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia","volume":"46","author":"Yang","year":"2014","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.jchromb.2024.123993_b0120","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1200\/JCO.2014.59.4671","article-title":"Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia","volume":"33","author":"Yang","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.jchromb.2024.123993_b0125","doi-asserted-by":"crossref","first-page":"13575","DOI":"10.18632\/oncotarget.14594","article-title":"Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose","volume":"8","author":"Yin","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.jchromb.2024.123993_b0130","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.2147\/OTT.S177007","article-title":"Associations between the NUDT15 R139C polymorphism and susceptibility to thiopurine-induced leukopenia in Asians: a meta-analysis","volume":"11","author":"Liu","year":"2018","journal-title":"OncoTargets and Therapy."},{"issue":"9","key":"10.1016\/j.jchromb.2024.123993_b0135","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00535-018-1486-7","article-title":"NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study","volume":"53","author":"Kakuta","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jchromb.2024.123993_b0140","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.18405","article-title":"Prominence of NUDT15 genetic variation associated with 6-mercaptopurine tolerance in a genome-wide association study of Japanese children with acute lymphoblastic leukaemia","author":"Tanaka","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.jchromb.2024.123993_b0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3508","article-title":"NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity","volume":"48","author":"Moriyama","year":"2016","journal-title":"Nat. Genet."},{"issue":"18","key":"10.1016\/j.jchromb.2024.123993_b0150","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1158\/0008-5472.CAN-16-0584","article-title":"NUDT15 hydrolyzes 6-thio-Deoxygtp to mediate the anticancer efficacy of 6-thioguanine","volume":"76","author":"Valerie","year":"2016","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jchromb.2024.123993_b0155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbapap.2019.01.006","article-title":"Thiopurine intolerance-causing mutations in NUDT15 induce temperature-dependent destabilization of the catalytic site","volume":"1867","author":"Man","year":"2019","journal-title":"Biochim Biophys Acta Proteins Proteom."},{"key":"10.1016\/j.jchromb.2024.123993_b0160","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.18375","article-title":"Low NUDT15 expression levels due to biallelic NUDT15 variants and 6-mercaptopurine intolerance","author":"Yoshida","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.jchromb.2024.123993_b0165","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood-2017-05-782383","article-title":"Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry","volume":"130","author":"Moriyama","year":"2017","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.jchromb.2024.123993_b0170","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/MIB.0000000000001148","article-title":"Combined detection of NUDT15 variants could highly predict thiopurine-induced leukopenia in chinese patients with inflammatory bowel disease","volume":"23","author":"Chao","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.jchromb.2024.123993_b0175","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3748\/wjg.v24.i4.511","article-title":"Influence of NUDT15 variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurines","volume":"24","author":"Kojima","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.jchromb.2024.123993_b0180","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jama.2019.0709","article-title":"Association of genetic variants in NUDT15 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease","volume":"321","author":"Walker","year":"2019","journal-title":"JAMA."},{"key":"10.1016\/j.jchromb.2024.123993_b0185","unstructured":"Guideline on Bioanalytical Method Validation in Pharmaceutical Development, 2013. https:\/\/www.nihs.go.jp\/drug\/BMV\/250913_BMV-GL_E.pdf. (Accessed 10.23 2023)."},{"key":"10.1016\/j.jchromb.2024.123993_b0190","unstructured":"RCoreTeam R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing 2023 Vienna, Austria."},{"issue":"3","key":"10.1016\/j.jchromb.2024.123993_b0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease","volume":"53","author":"Matsuoka","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jchromb.2024.123993_b0200","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/clinchem\/47.5.956","article-title":"Phenotype determination of thiopurine methyltransferase in erythrocytes by HPLC","volume":"47","author":"Boulieu","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2024.123993_b0205","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jpba.2017.07.039","article-title":"Development and validation of a reliable method for thiopurine methyltransferase (TPMT) enzyme activity in human whole blood by LC-MS\/MS: an application for phenotypic and genotypic correlations","volume":"145","author":"Wiwattanakul","year":"2017","journal-title":"J Pharm Biomed Anal."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:13:29Z","timestamp":1761606809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":41,"alternative-id":["S1570023224000011"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.123993","relation":{},"ISSN":["1570-0232"],"issn-type":[{"type":"print","value":"1570-0232"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measurement of the intracellular active metabolites of thiopurine drugs to evaluate the enzymatic activity of nudix hydrolase 15 in human blood samples","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.123993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123993"}}